skip to main content

VEDOSS Monitoring — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

HardAutoimmune SerologyVEDOSS MonitoringSCE Rheumatology

A 41-year-old has Raynaud phenomenon, puffy fingers, positive ANA and anti-centromere antibodies, but no skin thickening and normal echocardiography, lung function and renal profile. What is the most appropriate interpretation and plan?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Treat this as very-early systemic sclerosis and arrange specialist longitudinal surveillance

Explanation lettering: E = shown as A · D = shown as B · A = shown as D · B = shown as E

D is correct. Raynaud phenomenon plus puffy fingers and a systemic-sclerosis-specific autoantibody fits a VEDOSS-type high-risk phenotype. It does not automatically satisfy classification criteria or justify immunosuppression, but it should trigger specialist follow-up for evolution of skin, digital, gastrointestinal, cardiopulmonary and renal disease. A overdiagnoses established limited cutaneous disease and treats without an organ indication. B mistakes classification criteria for a one-time exclusion test. C exposes the patient to glucocorticoid toxicity and potential renal-crisis risk. E ignores that normal baseline tests are a surveillance starting point, not lifetime reassurance. Nailfold capillaroscopy can further refine risk but is not a substitute for longitudinal clinical assessment.

Reference: 2024 BSR guideline for management of systemic sclerosis: https://pmc.ncbi.nlm.nih.gov/articles/PMC11534099/